Chemical Reviews,
Journal Year:
2023,
Volume and Issue:
123(18), P. 10920 - 10989
Published: Sept. 15, 2023
Anticancer
nanomedicines
have
been
proven
effective
in
mitigating
the
side
effects
of
chemotherapeutic
drugs.
However,
challenges
remain
augmenting
their
therapeutic
efficacy.
Nanomedicines
responsive
to
pathological
abnormalities
tumor
microenvironment
(TME)
are
expected
overcome
biological
limitations
conventional
nanomedicines,
enhance
efficacies,
and
further
reduce
effects.
This
Review
aims
quantitate
various
TME,
which
may
serve
as
unique
endogenous
stimuli
for
design
stimuli-responsive
provide
a
broad
objective
perspective
on
current
understanding
cancer
treatment.
We
dissect
typical
transport
process
barriers
drug
delivery,
highlight
key
principles
designed
tackle
series
delivery
process,
discuss
"all-into-one"
"one-for-all"
strategies
integrating
needed
properties
nanomedicines.
Ultimately,
we
insight
into
future
perspectives
toward
clinical
translation
Cancers,
Journal Year:
2019,
Volume and Issue:
11(5), P. 640 - 640
Published: May 8, 2019
Targeting
nanoparticle
(NP)
carriers
to
sites
of
disease
is
critical
for
their
successful
use
as
drug
delivery
systems.
Along
with
optimization
physicochemical
properties,
researchers
have
focused
on
surface
modification
NPs
biological
ligands.
Such
ligands
can
bind
specific
receptors
the
target
cells.
Furthermore,
facilitate
uptake
modified
NPs,
which
referred
‘active
targeting’
NPs.
In
this
review,
we
discuss
recent
applications
including
proteins,
polysaccharides,
aptamers,
peptides,
and
small
molecules
NP-mediated
delivery.
We
prioritized
studies
that
demonstrated
targeting
in
animals
over
vitro
studies.
expect
review
will
assist
biomedical
working
imaging.
Biomaterials Science,
Journal Year:
2020,
Volume and Issue:
8(17), P. 4653 - 4664
Published: Jan. 1, 2020
Nanomedicine
research
has
increased
drastically
over
the
past
ten
years,
however,
before
clinical
translation
many
regulatory
factors
must
be
considered.
ACS Nano,
Journal Year:
2020,
Volume and Issue:
14(3), P. 2585 - 2627
Published: Feb. 7, 2020
Nanotheranostics
is
one
of
the
biggest
scientific
breakthroughs
in
nanomedicine.
Most
currently
available
diagnosis
and
therapies
are
invasive,
time-consuming,
associated
with
severe
toxic
side
effects.
Nanotheranostics,
on
other
hand,
has
potential
to
bridge
this
gap
by
harnessing
capabilities
nanotechnology
nanomaterials
for
combined
therapeutics
diagnostics
markedly
enhanced
efficacy.
However,
nanomaterial
applications
nanotheranostics
still
its
infancy.
This
due
fact
that
each
disease
a
particular
microenvironment
well-defined
characteristics,
which
promotes
deeper
selection
criteria
meet
needs.
In
review,
we
have
outlined
how
designed
tailored
cancer
diseases
such
as
neurodegenerative,
autoimmune
(particularly
rheumatoid
arthritis),
cardiovascular
diseases.
The
penetrability
retention
biological
system,
therapeutic
strategy
used,
imaging
mode
selected
some
aspects
discussed
disease.
specific
properties
terms
feasibility,
physicochemical
challenges,
progress
clinical
trials,
toxicity,
their
future
application
translational
medicine
addressed.
Our
review
meticulously
critically
examines
various
nanomaterials,
including
graphene,
across
several
diseases,
offering
broader
perspective
emerging
field.
Proceedings of the National Academy of Sciences,
Journal Year:
2022,
Volume and Issue:
119(8)
Published: Feb. 16, 2022
Significance
The
current
application
of
messenger
RNA
(mRNA)-based
technology
has
largely
been
confined
to
liver
diseases
because
the
lack
a
specific
and
efficient
extrahepatic
in
vivo
systemic
mRNA
delivery
system.
Here,
we
have
developed
library
N-series
lipid
nanoparticles
(LNPs)
that
could
specifically
regulate
protein
composition
corona
on
surface
LNPs,
which
allows
lung.
We
further
demonstrated
our
lung-targeting
LNP
effectively
deliver
mouse
tuberous
sclerosis
complex
2
(
Tsc2
)
into
TSC2-null
cells
restore
its
function,
resulting
enhanced
control
tumor
burden
preclinical
model
lymphangioleiomyomatosis,
destructive
lung
disease
caused
by
loss-of-function
mutations
gene.
Frontiers in Bioengineering and Biotechnology,
Journal Year:
2020,
Volume and Issue:
8
Published: April 3, 2020
In
the
last
decades,
staggering
progress
in
nanotechnology
brought
around
a
wide
and
heterogeneous
range
of
nanoparticle-based
platforms
for
diagnosis
treatment
many
diseases.
Most
these
systems
are
designed
to
be
administered
intravenously.
This
administration
route
allows
nanoparticles
(NPs)
widely
distribute
body
reach
deep
organs
without
invasive
techniques.
When
nanovectors
encounter
biological
environment
systemic
circulation,
dynamic
interplay
occurs
between
circulating
proteins
NPs
themselves.
The
set
that
bind
surface
is
referred
as
protein
corona
(PC).
PC
has
critical
role
making
particles
easily
recognized
by
innate
immune
system,
causing
their
quick
clearance
phagocytic
cells
located
such
lungs,
liver,
spleen.
For
same
reason
defines
immunogenicity
priming
response
them
and,
ultimately,
immunological
toxicity.
Furthermore,
can
cause
physical
destabilization
agglomeration
particles.
These
problems
induced
consider
only
barrier
overcome
order
achieve
efficient
NPs-based
targeting.
review
will
discuss
latest
advances
characterization
PC,
development
stealthy
formulations,
well
manipulation
employment
an
alternative
resource
prolonging
half-life,
its
use
diagnostic
applications.
Chemical Society Reviews,
Journal Year:
2022,
Volume and Issue:
51(13), P. 5365 - 5451
Published: Jan. 1, 2022
The
present
review
details
a
chronological
description
of
the
events
that
took
place
during
development
mesoporous
materials,
their
different
synthetic
routes
and
use
as
drug
delivery
systems.
outstanding
textural
properties
these
materials
quickly
inspired
translation
to
nanoscale
dimension
leading
silica
nanoparticles
(MSNs).
aspects
introducing
pharmaceutical
agents
into
pores
nanocarriers,
together
with
possible
biodistribution
clearance
routes,
would
be
described
here.
smart
nanocarriers
are
able
release
high
local
concentration
therapeutic
cargo
on-demand
after
application
certain
stimuli
reviewed
here,
ability
deliver
precise
locations
in
body.
huge
progress
design
MSNs
for
biomedical
applications,
including
potential
treatment
diseases,
last
20
years
will
collated
required
work
still
needs
done
achieve
clinical
materials.
This
was
conceived
stand
out
from
past
reports
since
it
aims
tell
story
systems
by
some
makers,
who
could
considered
among
pioneers
this
area.
Communications Biology,
Journal Year:
2020,
Volume and Issue:
3(1)
Published: March 3, 2020
Abstract
The
practical
application
of
nanoparticles
(NPs)
as
chemotherapeutic
drug
delivery
systems
is
often
hampered
by
issues
such
poor
circulation
stability
and
targeting
inefficiency.
Here,
we
have
utilized
a
simple
approach
to
prepare
biocompatible
biodegradable
pH-responsive
hybrid
NPs
that
overcome
these
issues.
consist
drug-loaded
polylactic-co-glycolic
acid
(PLGA)
core
covalently
‘wrapped’
with
crosslinked
bovine
serum
albumin
(BSA)
shell
designed
minimize
interactions
proteins
macrophages
inhibit
target
recognition.
functionalized
the
acidity-triggered
rational
membrane
(ATRAM)
peptide
facilitate
internalization
specifically
into
cancer
cells
within
acidic
tumor
microenvironment.
Following
uptake,
unique
intracellular
conditions
degrade
NPs,
thereby
releasing
cargo.
showed
potent
anticancer
activity
in
vitro
vivo
while
exhibiting
no
toxicity
healthy
tissue.
Our
results
demonstrate
ATRAM-BSA-PLGA
are
promising
targeted
platform.
Proceedings of the National Academy of Sciences,
Journal Year:
2020,
Volume and Issue:
117(19), P. 10492 - 10499
Published: April 24, 2020
Protein
corona
formation
is
critical
for
the
design
of
ideal
and
safe
nanoparticles
(NPs)
nanomedicine,
biosensing,
organ
targeting,
other
applications,
but
methods
to
quantitatively
predict
protein
corona,
especially
functional
compositions,
remain
unavailable.
The
traditional
linear
regression
model
performs
poorly
as
measured
by
R
2
(less
than
0.40).
Here,
performance
with
over
0.75
in
prediction
was
achieved
integrating
a
machine
learning
meta-analysis.
NPs
without
modification
surface
were
identified
two
most
important
factors
determining
formation.
According
experimental
verification,
compositions
(e.g.,
immune
proteins,
complement
apolipoproteins)
complex
coronas
precisely
predicted
good
(most
0.80).
Moreover,
method
successfully
cellular
recognition
uptake
macrophages
cytokine
release)
mediated
proteins.
This
workflow
provides
accurately
composition
that
determines
nanotoxicity
guide
synthesis
applications
wide
range
overcoming
limitations
uncertainty.
Nature Communications,
Journal Year:
2019,
Volume and Issue:
10(1)
Published: Oct. 4, 2019
Abstract
Control
over
the
protein
corona
of
nanomaterials
allows
them
to
function
better.
Here,
by
taking
graphene/gold
as
examples,
we
comprehensively
assessed
association
surface
properties
with
corona.
As
revealed
in
vitro
measurements
and
computations,
interaction
between
HSA/IgE
was
inversely
correlated
hydroxyl
group
availability,
whereas
that
ApoE
comparatively
less
relevant.
Molecular
simulations
number
distribution
groups
could
regulate
manner
which
interact
proteins.
Moreover,
validated
pre-adsorption
before
injection
enhances
blood
circulation
relative
their
pristine
IgE-coated
counterparts.
This
benefit
can
be
attributed
invulnerability
complementary
system
provided
ApoE,
whose
encasement
does
not
increase
cytotoxicity.
Overall,
this
study
offers
a
robust
yet
simple
way
create
enriched
dysopsonins
realize
better
delivery
efficacy.